Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis
NM Intagliata, SH Caldwell, A Tripodi - Gastroenterology, 2019 - Elsevier
Portal vein thrombosis unrelated to solid malignancy is common in patients with cirrhosis,
but less frequently observed in patients without cirrhosis. Prompt diagnosis and …
but less frequently observed in patients without cirrhosis. Prompt diagnosis and …
Portal vein thrombosis
YK Chawla, V Bodh - Journal of clinical and experimental hepatology, 2015 - Elsevier
Portal vein thrombosis is an important cause of portal hypertension. PVT occurs in
association with cirrhosis or as a result of malignant invasion by hepatocellular carcinoma or …
association with cirrhosis or as a result of malignant invasion by hepatocellular carcinoma or …
EASL Clinical Practice Guidelines: Vascular diseases of the liver
European Association For The Study Of The Liver - Journal of hepatology, 2016 - Elsevier
Vascular disorders of the liver, although affecting less than 5/10,000 patients, collectively
account for a number of rare conditions that represent an important health problem …
account for a number of rare conditions that represent an important health problem …
TIPS for adults without cirrhosis with chronic mesenteric venous thrombosis and EHPVO refractory to standard‐of‐care therapy
Background and Aims Extrahepatic portal vein occlusion (EHPVO) from portal vein
thrombosis is a rare condition associated with substantial morbidity and mortality. The …
thrombosis is a rare condition associated with substantial morbidity and mortality. The …
Splanchnic venous thrombosis and pancreatitis
NA Nadkarni, S Khanna, SS Vege - Pancreas, 2013 - journals.lww.com
Pancreatitis is an inflammatory process with local and systemic manifestations. One such
local manifestation is thrombosis in splanchnic venous circulation, predominantly of the …
local manifestation is thrombosis in splanchnic venous circulation, predominantly of the …
Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction
F Artru, N Vietti-Violi, C Sempoux, JV Barbosa, F Becce… - JHEP reports, 2022 - Elsevier
Background & Aims We aimed to evaluate long-term outcome of patients with chronic non-
cirrhotic extrahepatic portal vein obstruction (CNC-EHPVO) who underwent portal vein …
cirrhotic extrahepatic portal vein obstruction (CNC-EHPVO) who underwent portal vein …
Mast cells regulate ductular reaction and intestinal inflammation in cholestasis through farnesoid X receptor signaling
Background and Aims Cholestasis is characterized by increased total bile acid (TBA) levels,
which are regulated by farnesoid X receptor (FXR)/FGF15. Patients with primary sclerosing …
which are regulated by farnesoid X receptor (FXR)/FGF15. Patients with primary sclerosing …
A prospective, multicentre study in acute non‐cirrhotic, non‐malignant portal vein thrombosis: comparison of medical and interventional treatment
M Rössle, D Bettinger, J Trebicka… - Alimentary …, 2020 - Wiley Online Library
Background To evaluate medical versus interventional treatment (transjugular thrombus
fragmentation, local thrombolysis with or without stent implantation) in patients with acute …
fragmentation, local thrombolysis with or without stent implantation) in patients with acute …
Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis
C Klinger, B Riecken, A Schmidt, A De Gottardi… - Digestive and liver …, 2017 - Elsevier
Background & aims Therapeutic anticoagulation is the standard treatment in patients with
acute non-cirrhotic portal vein thrombosis (PVT). In critically ill patients, anticoagulation only …
acute non-cirrhotic portal vein thrombosis (PVT). In critically ill patients, anticoagulation only …
Portal vein thrombosis: When to treat and how?
AM Sharma, D Zhu, Z Henry - Vascular Medicine, 2016 - journals.sagepub.com
Portal vein thrombosis is an unusual thrombotic condition not frequently seen in the general
population; however, it has a higher prevalence in special circumstances such as in liver …
population; however, it has a higher prevalence in special circumstances such as in liver …